News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
740,913 Results
Type
Article (43897)
Company Profile (266)
Press Release (696737)
Multimedia
Podcasts (100)
Webinars (20)
Section
Business (206151)
Career Advice (2213)
Deals (35781)
Drug Delivery (138)
Drug Development (82277)
Employer Resources (175)
FDA (16711)
Job Trends (15137)
News (349428)
Policy (33086)
Tag
2027 BioCapital Elite (1)
2027 BioCapital Standard (1)
2027 BioMidwest Elite (2)
2027 Bio NC Standard (1)
2027 Biotech Bay Elite (2)
2027 Biotech Bay Standard (3)
2027 Biotech Beach Elite (2)
2027 Genetown Elite (4)
2027 Genetown Standard (2)
2027 Pharm Country Elite (2)
2027 Pharm Country Standard (5)
Academia (2702)
Accelerated approval (55)
ADA (44)
Adcomms (31)
Allergies (192)
Alliances (50119)
ALS (227)
Alzheimer's disease (1847)
Antibody-drug conjugate (ADC) (511)
Approvals (17159)
Artificial intelligence (730)
ASCO (328)
Autoimmune disease (336)
Automation (62)
Bankruptcy (368)
Best Places to Work (11744)
BIO (63)
BIOSECURE Act (20)
Biosimilars (232)
Biotechnology (171)
Bladder cancer (202)
Brain cancer (74)
Breast cancer (796)
Cancer (6275)
Cardiovascular disease (507)
Career advice (1879)
Career pathing (45)
CAR-T (354)
CDC (61)
Celiac Disease (3)
Cell therapy (963)
Cervical cancer (54)
Clinical research (71888)
Collaboration (2203)
Commercialization (1)
Company closure (5)
Compensation (1493)
Complete response letters (88)
COVID-19 (2826)
CRISPR (118)
C-suite (1217)
Cystic fibrosis (158)
Data (8586)
Decentralized trials (3)
Denatured (30)
Depression (175)
Dermatology (96)
Diabetes (668)
Diagnostics (7078)
Digital health (63)
Diversity (13)
Diversity, equity & inclusion (45)
Drug discovery (356)
Drug pricing (209)
Drug shortages (32)
Duchenne muscular dystrophy (301)
Earnings (92323)
Editorial (68)
Employer branding (22)
Employer resources (155)
Events (121142)
Executive appointments (1117)
FDA (20678)
Fibrodysplasia Ossificans Progressiva (9)
Friedreich's ataxia (20)
Frontotemporal dementia (35)
Funding (1852)
Gene editing (246)
Generative AI (61)
Gene therapy (757)
GLP-1 (1110)
Government (4824)
Grass and pollen (7)
Guidances (420)
Healthcare (19388)
Hematology (193)
HIV (89)
Huntington's disease (62)
Idiopathic pulmonary fibrosis (1)
IgA nephropathy (110)
Immunology and inflammation (303)
Immuno-oncology (103)
Indications (214)
Infectious disease (3195)
Inflammatory bowel disease (223)
Inflation Reduction Act (14)
Influenza (142)
Intellectual property (315)
Interviews (373)
IPO (16721)
IRA (50)
Job creations (3682)
Job search strategy (1553)
JPM (59)
Kidney cancer (20)
Labor market (111)
Layoffs (589)
Leadership (42)
Legal (8026)
Liver cancer (104)
Longevity (35)
Lung cancer (830)
Lymphoma (472)
Machine learning (64)
Management (60)
Manufacturing (1144)
Marketing (2)
MASH (208)
Medical affairs (1)
Medical device (14138)
Medtech (14305)
Mergers & acquisitions (20353)
Metabolic disorders (1654)
mRNA (230)
Multiple sclerosis (200)
NASH (17)
Neurodegenerative disease (459)
Neuropsychiatric disorders (111)
Neuroscience (3487)
Neurotech (1)
NextGen: Class of 2026 (6624)
Non-profit (4617)
Now hiring (81)
Obesity (760)
Opinion (307)
Ovarian cancer (237)
Pain (271)
Pancreatic cancer (351)
Parkinson's disease (391)
Partnered (35)
Patents (633)
Patient recruitment (747)
Peanut (67)
People (60203)
Pharmaceutical (60)
Pharmacy benefit managers (33)
Phase 1 (22430)
Phase 2 (31675)
Phase 3 (23557)
Pipeline (9714)
Policy (336)
Postmarket research (2598)
Preclinical (9576)
Press Release (67)
Prostate cancer (334)
Psychedelics (60)
Radiopharmaceuticals (345)
Rare diseases (1167)
Real estate (6036)
Recruiting (71)
Regulatory (25957)
Reports (56)
Research institute (2504)
Resumes & cover letters (370)
Rett syndrome (43)
RNA editing (25)
RSV (91)
Schizophrenia (183)
Series A (317)
Series B (235)
Service/supplier (11)
Sickle cell disease (122)
Special edition (24)
Spinal muscular atrophy (171)
Sponsored (49)
Startups (3715)
State (2)
Stomach cancer (18)
Supply chain (137)
Tariffs (89)
The Weekly (67)
Vaccines (1165)
Venture capital (124)
Weight loss (493)
Women's health (136)
Worklife (21)
Date
Today (94)
Last 7 days (447)
Last 30 days (2618)
Last 365 days (30482)
2026 (15788)
2025 (30295)
2024 (35380)
2023 (40269)
2022 (51458)
2021 (56055)
2020 (54560)
2019 (47099)
2018 (35515)
2017 (32458)
2016 (31885)
2015 (37968)
2014 (31691)
2013 (26697)
2012 (28931)
2011 (29610)
2010 (27622)
Location
Africa (771)
Alabama (93)
Alaska (7)
Arizona (367)
Arkansas (14)
Asia (40388)
Australia (6698)
California (13937)
Canada (3931)
China (1474)
Colorado (594)
Connecticut (610)
Delaware (433)
Europe (88397)
Florida (2101)
Georgia (449)
Hawaii (3)
Idaho (64)
Illinois (1145)
India (96)
Indiana (633)
Iowa (24)
Japan (590)
Kansas (134)
Kentucky (51)
Louisiana (58)
Maine (76)
Maryland (1657)
Massachusetts (9982)
Michigan (376)
Minnesota (757)
Mississippi (6)
Missouri (148)
Montana (33)
Nebraska (30)
Nevada (149)
New Hampshire (84)
New Jersey (3678)
New Mexico (31)
New York (3661)
North Carolina (1755)
North Dakota (9)
Northern California (7030)
Ohio (416)
Oklahoma (23)
Oregon (42)
Pennsylvania (2770)
Puerto Rico (31)
Rhode Island (54)
South America (1140)
South Carolina (87)
South Dakota (2)
Southern California (5523)
Tennessee (225)
Texas (2235)
United States (49200)
Utah (417)
Vermont (2)
Virginia (343)
Washington D.C. (82)
Washington State (1108)
West Virginia (4)
Wisconsin (132)
Wyoming (2)
740,913 Results for "abl inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Hyundai Bioscience: “Able to Supply Antiviral Drug in Event of Ebola or Hantavirus Spread”
May 20, 2026
·
1 min read
Press Releases
Precipio Announces Publication of a Joint Study with Memorial Sloan-Kettering Cancer Center Highlighting Its Cutting-Edge Bloodhound BCR::ABL1 Assay
March 10, 2026
·
6 min read
Neuroscience
GSK Dives Deeper Into Neuro With $2.5B+ ABL Bio Pact
GSK is paying to access ABL Bio’s Grabody-B platform, which potentially enables therapies to cross the blood-brain barrier.
April 7, 2025
·
2 min read
·
Tristan Manalac
RNA editing
Lilly targets kidney disease with Ascidian’s RNA exon editors for up to $1.9B
For an investment of up to $1.9 billion, Eli Lilly will be able to use Ascidian Therapeutics’ platform that removes mutated exons from mRNA molecules, avoiding the expression of disease-causing proteins.
June 3, 2026
·
2 min read
·
Tristan Manalac
Press Releases
ABL Bio Receives Upfront Payment for License, Research and Collaboration Agreement for Grabody Platform and Equity Investment from Lilly
December 29, 2025
·
2 min read
Press Releases
Precipio to Showcase its BCR::ABL1 panel at 2025 ASH (American Society of Hematology) Meeting
December 8, 2025
·
4 min read
Obesity
ADA: Metsera asset data support Pfizer’s ‘entry point’ into obesity market
Much work needs to be done for Pfizer to be able to catch up to the weight-loss frontrunners, according to Guggenheim Partners, but new data from Metsera’s lead asset could set the pharma apart from competitors with a monthly injection.
June 8, 2026
·
4 min read
·
Tristan Manalac
Press Releases
Shattuck Labs, Inc. Announces Proposed Public Offering
June 10, 2026
·
5 min read
Press Releases
Shattuck Labs, Inc. Announces Pricing of $75 Million Public Offering
June 10, 2026
·
5 min read
Press Releases
Neural Therapeutics Inc. Announces Transition to Semi-Annual Financial Reporting
June 19, 2026
·
5 min read
1 of 74,092
Next
